A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies

被引:0
|
作者
Bentivegna, Sofia [1 ,2 ]
Almosailleakh, Marwa [1 ,2 ]
Zhao, Lin-Pierre [3 ,4 ]
Schuster, Mikkel Bruhn [2 ,5 ]
Benquet, Sebastien [2 ]
Balhuizen, Alexander [2 ]
Munch-Petersen, Helga Fibiger [6 ]
Sjo, Lene Dissing
Andersen, Mads Hald [7 ,8 ]
Dulphy, Nicolas [4 ,9 ,10 ]
Porse, Bo [2 ,5 ,11 ]
Gronbaek, Kirsten [1 ,2 ,11 ]
机构
[1] Rigshosp Copenhagen Univ Hosp, Dept Hematol, Copenhagen, Denmark
[2] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark
[3] Hop St Louis, Assistance Publ Hop Paris, Paris, France
[4] Univ Paris Cite, Inst Rech St Louis, INSERM UMR 1160, Paris, France
[5] Rigshosp Copenhagen Univ Hosp, Finsen Lab, Copenhagen, Denmark
[6] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Copenhagen, Denmark
[7] Copenhagen Univ Hosp, Natl Ctr Canc Immune Therapy CCIT DK, Dept Oncol, Herlev, Denmark
[8] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark
[9] Hop St Louis, Assistance Publ Hop Paris APHP, Lab Immunol & Histocompatibil, Paris, France
[10] Hop St Louis, Inst Carnot OPALE, Inst Rech St Louis, Paris, France
[11] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
基金
欧盟地平线“2020”;
关键词
RISK;
D O I
10.1186/s40164-025-00598-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clonal hematopoiesis of indeterminate potential (CHIP) is a condition where blood or bone marrow cells carry mutations associated with hematological malignancies. Individuals with CHIP have an increased risk of developing hematological malignancies, atherosclerotic cardiovascular disease, and all-cause mortality. Bone marrow transplantation (BMT) of cells carrying CHIP mutations into irradiated mice are useful procedures to investigate the dynamics of clonal expansion and potential therapeutic strategies, but myeloablative conditioning can induce confounding effects. We established a non-conditioned BMT model using C57BL/6J-Kit(W-41J)/J (W-41) recipient mice to overcome the unwanted effects of irradiation. Conditional Tet2 deletion using tamoxifen was used to obtain Tet2(-/-) cells from donor mice. Total BM Tet2(-/-) cells were transplanted into W-41 recipients, and longitudinal and terminal analyses at 10 months post-BMT were performed. We showed that W-41 mice can be used for BMT procedures without myeloablative pre-conditioning. The transplantation of Tet2(-/-) BM cells led to a progressive expansion of the donor cells in W-41 recipients. By modulating the numbers of Tet2(-/-) cells transplanted, recipient mice developed features of clonal hematopoiesis or myeloid malignancies. In conclusion, our model is an alternative to conventional irradiation-based transplantation models to study mechanisms underlying malignant hematopoiesis without confounding effects derived from pre-conditioning regimen.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies
    GA Hale
    HE Heslop
    LC Bowman
    RA Rochester
    C-H Pui
    MK Brenner
    RA Krance
    Bone Marrow Transplantation, 1999, 24 : 735 - 739
  • [32] Comparative Behaviour of Allogeneic Spleen versus Bone Marrow Cells in Non-Conditioned Neonatal Mice: Insights into Robust Heart Transplant Tolerance
    Bascom, R. A.
    Tao, K.
    West, L. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S254 - S254
  • [33] Lymphohematopoietic stem cells from donor origin are preserved in bone marrow implants beneath the renal capsule of non-conditioned host mice
    Grande, T
    Varas, F
    Ramirez, A
    Bueren, JA
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 128 - 128
  • [34] HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE AS ABLATIVE THERAPY FOR BONE-MARROW TRANSPLANTATION IN MYELOID MALIGNANCIES
    GUMBART, CH
    SORENSEN, SH
    CLINICAL RESEARCH, 1988, 36 (01): : A25 - A25
  • [35] Second cancers after non-autologous bone marrow transplantation for hematologic malignancies
    Kulkarni, S
    Powles, R
    Singhal, S
    Mehta, J
    Treleaven, J
    Horton, C
    Meller, S
    Pinkerton, CR
    Atra, A
    Tait, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 211 - 211
  • [36] Therapeutic Effects of Circulation Derived Myeloid Cell Engraftment Following Bone Marrow Transplantation in Chronic EAE Mouse Model
    Wu, D.
    Mader, M.
    Napole, A.
    Scarvetti, A.
    Wernig, M.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 110 - 110
  • [37] ROLE OF INTRATHYMIC CLONAL DELETION AND PERIPHERAL ANERGY IN TRANSPLANTATION TOLERANCE INDUCED BY BONE-MARROW TRANSPLANTATION IN MICE CONDITIONED WITH A NONMYELOABLATIVE REGIMEN
    TOMITA, Y
    KHAN, A
    SYKES, M
    JOURNAL OF IMMUNOLOGY, 1994, 153 (03): : 1087 - 1098
  • [38] Bone marrow transplantation improves motor activity in a mouse model of ataxia
    Diaz, David
    Piquer-Gil, Marina
    Sanchez Recio, Javier
    Magdalena Martinez-Losa, Maria
    Ramon Alonso, Jose
    Weruaga, Eduardo
    Alvarez-Dolado, Manuel
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2018, 12 (04) : E1950 - E1961
  • [39] A new mouse model of leukemia relapse in bone marrow transplantation.
    Castro, JG
    Seqovia, JC
    Bueren, JA
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 71 - 71
  • [40] COMPARATIVE STUDY OF BONE MARROW ASPIRATION AND BONE MARROW TREPHINE BIOPSY IN HAEMATOLOGICAL AND NON-HAEMATOLOGICAL MALIGNANCIES
    Dwivedi, Shobha
    Nigam, Sanjay Kumar
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (31): : 5773 - 5798